Denmark among the favourites to land the European Medicines Agency
As a consequence of Brexit, the European Medicines Agency (EMA), which for now is based in the UK, needs a new residence, and Denmark seems to be an early favourite in the race. Danish politicians, interest organisations, scientists and several companies are all backing the candidacy. Kromann Reumert also sees a great potential in Denmark being the home of the EMA.
Denmark and the city of Copenhagen is believed to be among the frontrunners along with Sweden, Spain and Ireland. In total twenty nations have officially shown interest in securing the EMA.
In a recent push to win the EMA, the Danish Prime Minister Lars Løkke Rasmussen, Foreign Minister Anders Samuelsen, Mayor of Copenhagen Frank Jensen and former CEO of Novo Nordisk Lars Rebien Sørensen have all been lobbying the EU, and the Danish government has already rented the Copenhagen Towers in Ørestad to house the EMA.
The EMA is a very attractive agency to win. With it comes more than 900 employees, 36,000 yearly visitors and an economic lift worth an estimated €1 billion. Winning the race for the EMA would instantly benefit Denmark and the healthcare industry. Nicolaj Bording, partner in Kromann Reumert, explains why:
"Getting the EMA to Copenhagen is of course about the prestige that follows, but it is much more than that. Denmark is one of the leading nations in healthcare research and development. We have some of the best healthcare companies in the world and are known for our innovative mindset. Relocating EMA to Copenhagen would be a natural choice and create hundreds of job opportunities, which will further strengthen the Danish healthcare sector."
The European Union will announce the place for the relocation in November 2017.
If you wish to learn more about the development of or the legal opportunities within the healthcare sector, please feel free to contact our Healthcare team.
Watch the promotional video here.